
V-jun stimulates both cdk2 kinase activity and g1/s progression via transcriptional repression of p21 cip1
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
ABSTRACT Previous studies have shown that the viral Jun (v-Jun) oncoprotein induces marked alterations in cell cycle control, which are associated with, and may be caused by, increased cdk2
kinase activity. Since p21 CIP1 is an important regulator of cdk2, we investigated whether aberrant expression of this cyclin-dependent kinase inhibitor might contribute to cell cycle
deregulation by v-Jun. We find that the basal levels of p21 CIP1 mRNA and protein expression are greatly reduced in chick embryo fibroblasts (CEF) transformed by v-Jun, and that v-Jun blocks
the increases in p21 CIP1 expression that normally accompany growth inhibition induced by serum deprivation or confluency in untransformed CEF. Importantly, ectopic expression of p21 CIP1
in v-Jun-transformed CEF inhibits both cdk2 kinase activity and cell cycle progression, indicating that these alterations in p21 CIP1 expression are likely to be functionally significant for
growth deregulation. We also investigated the mechanism through which v-Jun disturbs p21 CIP1 expression and the possible involvement of a known p21 CIP1 regulator, p53, as an intermediate
in this process. This analysis revealed that repression is mediated primarily at the level of p21 CIP1 gene transcription, however the mechanism is complex; both p53-dependent and
-independent mechanisms contribute as judged by analysis of p21 CIP1 promoter mutants and other assays of p53 transcriptional activity. Access through your institution Buy or subscribe This
is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 50 print issues and online access $259.00
per year only $5.18 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated
during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS THE PNUTS-PP1
COMPLEX ACTS AS AN INTRINSIC BARRIER TO HERPESVIRUS KSHV GENE EXPRESSION AND REPLICATION Article Open access 02 December 2022 PARP14 REGULATES CYCLIN D1 EXPRESSION TO PROMOTE CELL-CYCLE
PROGRESSION Article 22 June 2021 E6-MEDIATED ACTIVATION OF JNK DRIVES EGFR SIGNALLING TO PROMOTE PROLIFERATION AND VIRAL ONCOPROTEIN EXPRESSION IN CERVICAL CANCER Article Open access 10
December 2020 REFERENCES * Bader AG, Schneider ML, Bister K and Hartl M . (2001). _Oncogene_, 20, 7524–7535. * Blalock WL, Pearce M, Steelman LS, Franklin RA, McCarthy SA, Cherwinski H,
McMahon M and McCubrey JA . (2000). _Oncogene_, 19, 526–536. * Chen BK and Chang WC . (2000). _Proc. Natl. Acad. Sci. USA_, 97, 10406–10411. * Claassen GF and Hann SR . (2000). _Proc. Natl.
Acad. Sci. USA_, 97, 9498–9503. * Clark W, Black EJ, MacLaren A, Kruse U, LaThangue N, Vogt PK and Gillespie DA . (2000). _Mol. Cell. Biol._, 20, 2529–2542. * Clark W and Gillespie DA .
(1997). _Cell Growth Differ._, 8, 371–380. * Coller HA, Grandori C, Tamayo P, Colbert T, Lander ES, Eisenman RN and Golub TR . (2000). _Proc. Natl. Acad. Sci. USA_, 97, 3260–3265. * Cox LS .
(1997). _J. Pathol._, 183, 134–140. * Datto MB, Yu Y and Wang XF . (1995). _J. Biol. Chem._, 270, 28623–28628. * el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D,
Mercer WE, Kinzler KW and Vogelstein B . (1993). _Cell_, 75, 817–825. * Erhardt JA and Pittman RN . (1998). _Oncogene_, 16, 443–451. * Fu S, Bottoli I, Goller M and Vogt PK . (1999). _Proc.
Natl. Acad. Sci. USA_, 96, 5716–5721. * Fu SL, Waha A and Vogt PK . (2000). _Oncogene_, 19, 3537–3545. * Gao M, Morgan I and Vogt PK . (1996). _Cancer Res._, 56, 4229–4235. * Gartel AL and
Tyner AL . (1999). _Exp. Cell Res._, 246, 280–289. * Gartel AL, Ye X, Goufman E, Shianov P, Hay N, Najmabadi F and Tyner AL . (2001). _Proc. Natl. Acad. Sci. USA_, 98, 4510–4515. * Gervais
JL, Seth P and Zhang H . (1998). _J. Biol. Chem._, 273, 19207–19212. * Givol I, Givol D, Rulong S, Resau J, Tsarfaty I and Hughes SH . (1995). _Oncogene_, 11, 2609–2618. * Haapajarvi T,
Kivinen L, Heiskanen A, des Bordes C, Datto MB, Wang XF and Laiho M . (1999). _Exp. Cell Res._, 248, 272–279. * Hadman M, Gabos L, Loo M, Sehgal A and Bos TJ . (1996). _Oncogene_, 12,
135–142. * Hall M and Peters G . (1996). _Adv. Cancer Res._, 68, 67–108. * Hartl M and Bister K . (1995). _Proc. Natl. Acad. Sci. USA_, 92, 11731–11735. * Hartwell LH and Kastan MB . (1994).
_Science_, 266, 1821–1828. * Juven T, Barak Y, Zauberman A, George DL and Oren M . (1993). _Oncogene_, 8, 3411–3416. * Kardassis D, Papakosta P, Pardali K and Moustakas A . (1999). _J.
Biol. Chem._, 274, 29572–29581. * Kilbey A, Black EJ, Unlu M and Gillespie DA . (1996). _Oncogene_, 12, 2409–2418. * LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS,
Fattaey A and Harlow E . (1997). _Genes Dev._, 11, 847–862. * MacLaren A, Clark W and Gillespie DA . (2000). _Oncogene_, 19, 5906–5918. * Macleod KF, Sherry N, Hannon G, Beach D, Tokino T,
Kinzler K, Vogelstein B and Jacks T . (1995). _Genes Dev._, 9, 935–944. * Maki Y, Bos TJ, Davis C, Starbuck M and Vogt PK . (1987). _Proc. Natl. Acad. Sci. USA_, 84, 2848–2852. * Mitchell KO
and El-Deiry WS . (1999). _Cell Growth Differ._, 10, 223–230. * Ries S, Biederer C, Woods D, Shifman O, Shirasawa S, Sasazuki T, McMahon M, Oren M and McCormick F . (2000). _Cell_, 103,
321–330. * Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D and Goldberg AL . (1994). _Cell_, 78, 761–771. * Schreiber M, Kolbus A, Piu F, Szabowski A, U Mh-S, Tian J, Karin
M, Angel P and Wagner EF . (1999). _Genes Dev._, 13, 607–619. * Shaulian E, Schreiber M, Piu F, Beeche M, Wagner EF and Karin M . (2000). _Cell_, 103, 897–907. * Tsao YP, Li LY, Tsai TC and
Chen SL . (1996). _J. Virol._, 70, 7535–7539. * Vogt PK . (2001). _Oncogene_, 20, 2365–2377. * Vogt PK and Bos TJ . (1990). _Adv. Cancer Res._, 55, 1–35. * Waldman T, Lengauer C, Kinzler KW
and Vogelstein B . (1996). _Nature_, 381, 713–716. * Wang CH, Tsao YP, Chen HJ, Chen HL, Wang HW and Chen SL . (2000). _Biochem. Biophys. Res. Commun._, 270, 303–310. * Wu RC and Schonthal
AH . (1997). _J. Biol. Chem._, 272, 29091–29098. Download references ACKNOWLEDGEMENTS This work is supported by Cancer Research UK. The authors thank the following for the provision of
reagents—M Oren, X Wang, N Perkins, and K Ryan and J Wyke for comments on the manuscript. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Beatson Institute for Cancer Research, Garscube
Estate, Switchback Road, Bearsden, Glasgow, G61 1BD A Maclaren, W Clark & E J Black * Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK D A F
Gillespie * Division of Gene Regulation and Expression, School of Life Sciences, MSI/WTB Complex, Dow Street, University of Dundee, DD1 5EH, UK D Gregory * Cancer Research UK Developmental
Genetics Laboratory, Lincoln's Inn Fields, WC2A 3PX, UK H Fujii Authors * A Maclaren View author publications You can also search for this author inPubMed Google Scholar * W Clark View
author publications You can also search for this author inPubMed Google Scholar * E J Black View author publications You can also search for this author inPubMed Google Scholar * D Gregory
View author publications You can also search for this author inPubMed Google Scholar * H Fujii View author publications You can also search for this author inPubMed Google Scholar * D A F
Gillespie View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to A Maclaren. RIGHTS AND PERMISSIONS Reprints and
permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Maclaren, A., Clark, W., Black, E. _et al._ v-Jun stimulates both cdk2 kinase activity and G1/S progression via transcriptional repression of
p21 CIP1. _Oncogene_ 22, 2383–2395 (2003). https://doi.org/10.1038/sj.onc.1206329 Download citation * Received: 04 September 2002 * Revised: 12 December 2002 * Accepted: 12 December 2002 *
Published: 25 April 2003 * Issue Date: 24 April 2003 * DOI: https://doi.org/10.1038/sj.onc.1206329 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this
content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative
KEYWORDS * Jun * p21CIP1 * p53